This webinar covers the use of physiologically-based pharmacokinetic (PBPK) modeling in pregnancy and lactation studies and explains how PBPK can be used to estimate fetal drug exposure during pregnancy and the impact of lactation on drug exposure to neonates.At the end of this webinar attendees should have a better understanding of:1. PBPK modeling and its utility to predict drug exposure2. Incorporating pregnancy and lactation descriptions into PBPK models3. Estimating drug exposure for fetuses and neonates using modeling